Disc Medicine, Inc. (IRON)

Disc Medicine, Inc. (IRON) is a healthcare company (biotechnology) based in the United States. The share price is $77.20, up 0.80% on the day, which values the company at $3.52B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$77.20+0.80% today
Market value
$3.52B
200-week average
$56.1637% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Disc Medicine, Inc. in more detail

IRON trades at -12.4× next year's expected earnings. It sits 37% above its 200-week average of $56.16.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

2 of the superinvestors tracked here hold IRON, including Peter Kolchinsky (1.6% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding IRON

2 of the investors tracked here report a position in their latest 13F filing.

Disc Medicine, Inc. (IRON): questions and answers

What is Disc Medicine, Inc.'s market cap?

Disc Medicine, Inc. is valued at $3.52B at a share price of $77.20.

Is IRON above its 200-week moving average?

Yes. IRON is 37.5% above its 200-week average of $56.16. Long-term investors watch that line because strong companies rarely trade below it for long.

Does IRON pay a dividend?

Disc Medicine, Inc. does not currently pay a regular dividend.

Which famous investors own IRON?

In their latest quarterly filings, Peter Kolchinsky (1.6% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold IRON. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Disc Medicine, Inc. (IRON) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/IRON

Underlying data: Yahoo Finance; company filings with the SEC.